Photo: Rami Manochakian/ASCO
Jun 7, 2023, 10:31
After TKI , adding Pembro to chemo DOES NOT improve OS – Rami Manochakian
NEGATIVE results of Keynote789 trial:
Platinum + Pem +/- Pembro for TKI-resistant EGFR mutant NSCLC
❌PFS HR 0.8, P=0.0122
mPFS: 5.6 vs 5.5 mths
❌OS HR 0.84, P=0.0362
mOS: 15.9 vs 14.7 mths
After TKI , adding Pembro to chemo DOES NOT improve OS
Source: Rami Manochakian / Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 14:56
Nov 21, 2024, 14:41
Nov 21, 2024, 13:55
Nov 21, 2024, 13:46
Nov 21, 2024, 13:25
Nov 21, 2024, 12:57
Nov 21, 2024, 12:54
Nov 21, 2024, 12:49